HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

EAN News Network

Multiple sclerosis experts discuss data from four presentations on ozanimod, a disease modifying therapy that was presented at EAN 2022.

EP. 1: Brain and Cognitive Changes in Multiple Sclerosis

June 29th 2022

Dr DeLuca provides an overview of changes in cognition and brain volume loss in patients with multiple sclerosis.

EP. 2: Association Between Brain Volume and Long-term Cognition in Relapsing Multiple Sclerosis

July 6th 2022

Multiple sclerosis expert, Dr DeLuca, shares study design and clinical data on the association between brain volume and long-term cognition in patients with relapsing MS.

EP. 3: Cognitive Care Recommendations

July 6th 2022

Dr DeLuca shares his advice and recommendations from National MS Society on providing cognitive care for patients suffering from MS.

EP. 4: Factors Necessitating Treatment Change in Multiple Sclerosis

July 27th 2022

A multiple sclerosis expert, Dr Gabrielle Macaron, discusses factors that can lead to a change of therapy for patients with multiple sclerosis.

EP. 5: Ozanimod in DMT Naïve vs Experienced Patients with Relapsing Multiple Sclerosis

July 27th 2022

Dr Gabrielle Macaron reviews data with ozanimod in treatment naïve vs experienced patients with relapsing multiple sclerosis presented at EAN 2022.

EP. 6: Clinical Pearls for MS Management in Everyday Practice

July 27th 2022

Dr Macaron shares her interpretation of the data and importance of individualizing treatment for patients with multiple sclerosis.

EP. 7: Treatment Discontinuation in Multiple Sclerosis

July 29th 2022

Dr Wallace Brownlee discusses reasons of and clinical impact of treatment discontinuation in multiple sclerosis.

EP. 8: Relapse Following Discontinuation of Ozanimod

July 29th 2022

A multiple sclerosis expert, Dr Brownlee shares study design and clinical data on relapse following discontinuation of ozanimod in patients with multiple sclerosis.

EP. 9: Implications of Ozanimod Discontinuation Data for MS Care

July 29th 2022

Dr Brownlee shares his advice and recommendations from national MS society on providing cognitive care for patients suffering from MS.

EP. 10: Managing Relapses in Patients With Multiple Sclerosis

August 4th 2022

Dr Darin Okuda discusses strategies for treatment selection and management of relapses in multiple sclerosis.